TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.

Lingfang Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.